Leaflet ONKOTRONE 2mg / ml concentrate for solution for injection
Indicated for: cancer
Route of administration: injectable
Substance: mitoxantrone (antineoplastic agent)
ATC: L01DB07 (Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Mitoxantrone is an antineoplastic agent used for the treatment of acute myeloid leukemia, non-Hodgkin's lymphomas, and advanced prostate cancer. It works by intercalating into DNA and inhibiting its synthesis, leading to tumor cell death.
The medication is administered via intravenous infusion, usually in treatment cycles, with the dose adjusted based on the patient's weight and response to therapy. Common side effects include nausea, vomiting, myelosuppression, and alopecia.
Mitoxantrone is contraindicated in patients with severe hepatic impairment or hypersensitivity to the active substance. Its use also requires careful monitoring of cardiac function and blood counts.
This medication is an effective option for the treatment of hematological cancers and other tumor types, helping to improve patient outcomes.
General data about ONKOTRONE 2mg / ml
- Substance: mitoxantrone
- Date of latest medicines list: 01-06-2026
- Product code: W70296002
- Concentration: 2mg / ml
- Pharmaceutical form: concentrate for solution for injection
- Quantity: 1
- Product type: Generic medicine
- Price: 645.59 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for mitoxantrone
Concentrations available for mitoxantrone
- 20mg/10ml
- 2mg/ml
Compensation lists for ONKOTRONE 2mg / ml Baxter
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
645.59 RON
645.59 RON
0.00 RON